CME vs MKSI · P/E 22, rev $3.59B vs P/E 93, rev $2.33B
CME Group Inc (CME) versus MKS Instruments Inc (MKSI) — a side-by-side from cached financials, not a winner call.
CME Group Inc (CME) is a financial data & stock exchanges company listed on NASDAQ.
MKS Instruments Inc (MKSI) is a scientific & technical instruments company listed on US.
Latest reported CME revenue for 2026-06-30 was $3.59B. Net income was $2.20B. Revenue was up 90.8% from 2026-03-31 to 2026-06-30. CME currently screens at market cap $91.25B and trailing P/E 21.9.
Latest reported MKSI revenue for 2026-06-30 was $2.33B. Net income was $258.0M. MKSI currently screens at market cap $30.04B and trailing P/E 93.4.
CME currently screens at market cap $91.25B and trailing P/E 21.9. MKSI currently screens at market cap $30.04B and trailing P/E 93.4.
Not investment advice. Open the CME and MKSI stock pages for the full models.
Not investment advice.